๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT ยท Real-Time Price ยท USD
8.02
-0.59 (-6.85%)
At close: Nov 20, 2026, 4:00 PM EST
7.90
-0.12 (-1.50%)
After-hours: Nov 20, 2026, 7:58 PM EST

MiNK Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.2-----
Revenue Growth
------
Gross Profit
0.2-----
Operating Income
-11.44-12.64-11.29-22.92-30.95-18.61
Net Income
-11.02-12.49-10.78-22.46-27.99-30.21
Earnings Per Share
-2.25-2.93-2.86-6.54-8.31-11.61
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7.4713.364.583.3719.6438.89
Total Debt
-5.184.92---
Net Cash (Debt)
7.478.18-0.353.3719.6438.89
Net Cash Growth
-12.68%---82.85%-49.51%-
Net Cash Per Share
1.521.92-0.090.985.8314.94

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.16-5.93-9.56-15.76-18.87-12.83
Capital Expenditures
-0.06---0.07-0.25-0.25
Free Cash Flow
-7.22-5.93-9.56-15.84-19.12-13.08
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%-----
Operating Margin
-5720.70%-----
Profit Margin
-5512.48%-----
FCF Margin
-3610.74%-----

Valuation

Selected indicators aren't available for this stock.